Why the study?
Does elevated serum NT-proBNP concentration predict prognosis in patients with hypertrophic cardiomyopathy?
Does elevated serum NT-proBNP concentration predict prognosis in patients with hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Elevated NT-proBNP serves as a strong prognostic marker for heart failure-related death and transplantation in patients with hypertrophic cardiomyopathy.
In patients with HCM, elevated NT-proBNP concentration is a strong predictor of overall prognosis, particularly HF-related death and transplantation.
No takes yet. Share an insight, caveat, or question.
Coats et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: